CIK 0001266806
- Non-accelerated filer
- Smaller reporting company
Vivani Medical, Inc.
Sign in to watch- Ticker
- VANI
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 020692322
- Phone
- +1 415-506-8462
- Business address
- 1350 S. LOOP ROAD, ALAMEDA, CA, 94502
- Former names
- SECOND SIGHT MEDICAL PRODUCTS INC, SECOUND SIGHT MEDICAL PRODUCTS INC
- Open-market buys, last 90 days
- $67,408
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$67,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 36 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-04 | Cosendai Gregoire VP Clinical Affairs | Grant or award · Non-Qualified Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2018-01-04 | OKLAND STEPHEN D Commercial VP, North America | Grant or award · Non-Qualified Stock Option (right to buy) | +140,000 | 140,000 | ||
| 2017-12-01 | Randolph Edward David Vice President of Manufacturin | Grant or award | −18,553 | $1.25 | $23K | 22 |
| 2017-11-30 | Randolph Edward David Vice President of Manufacturin | Grant or award | +18,553 | $0.96 | $18K | 18,575 |
| 2017-11-21 | Williams Gregg Director | Purchase | +24,604 | $1.19 | $29K | 19,482,572 |
| 2017-11-21 | McGuire Jonathan Will Chief Executive Officer | Returned to the company | −4,522 | $1.18 | $5K | 81,339 |
| 2017-11-21 | McGuire Jonathan Will Chief Executive Officer | Option exercise · Restricted Stock Unit (RSU) | −11,875 | 83,125 | ||
| 2017-11-20 | McGuire Jonathan Will Chief Executive Officer | Option exercise | +11,875 | $1.19 | $14K | 85,861 |
| 2017-11-20 | Williams Gregg Director | Purchase | +11,600 | $1.18 | $14K | 19,457,968 |
| 2017-11-17 | Williams Gregg Director | Purchase | +5,420 | $1.17 | $6K | 19,446,368 |
| 2017-08-30 | McGuire Jonathan Will Chief Executive Officer | Returned to the company | −4,921 | $1.08 | $5K | 73,986 |
| 2017-08-30 | McGuire Jonathan Will Chief Executive Officer | Option exercise · Restricted Stock Unit (RSU) | −11,875 | 95,000 | ||
| 2017-08-18 | McGuire Jonathan Will Chief Executive Officer | Option exercise | +11,875 | $0.97 | $12K | 78,907 |
| 2017-06-05 | Greenberg Robert J. Chairman of Board | Grant or award | −13,090 | $1.13 | $15K | 172,911 |
| 2017-06-01 | LINK WILLIAM J PHD Director | Grant or award | +58,021 | $1.17 | $68K | 80,668 |
| 2017-06-01 | Williams Gregg Director | Grant or award | +56,314 | $1.17 | $66K | 19,440,948 |
| 2017-06-01 | PFEFFER MATTHEW J Director | Grant or award | +59,725 | $1.17 | $70K | 82,768 |
| 2017-06-01 | Mendelsohn Aaron Director | Grant or award | +49,488 | $1.17 | $58K | 104,365 |
| 2017-05-31 | Greenberg Robert J. Chairman of Board | Grant or award | +13,090 | $0.98 | $13K | 186,001 |
| 2017-05-22 | MILLER THOMAS B Chief Financial Officer | Purchase · Warrant to Purchase Common Stock | +5,200 | $0.36 | $2K | 75,635 |
Page 28 of 31 · 601 trades